Trius Therapeutics Inc (TSRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

6310 NANCY RIDGE DR SUITE 105 SAN DIEGO, CA 92121

Trius Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibiotics for serious, life-threatening infections in the United States. Its products under development include Torezolid Phosphate, which has completed phase 2 clinical trials for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus. The company is also developing antibiotics for gram-negative infections using its proprietary discovery platform under a contract funded by the National Institutes of Health. It has a cooperative research and development agreement with Lawrence Livermore National Security, LLC for the research and development of gram-negative biodefense pathogens; and a license agreement with Dong-A Pharmaceutical Co., Ltd. to develop and sell Torezolid Phosphate outside of Korea.

View SEC Filings from TSRX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TSRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TSRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ATWOOD BRIAN G

  • Director
No longer subject to file 2013-09-11 0

KJELLSON NINA S

  • Director
No longer subject to file 2013-09-11 0

FINN JOHN CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2013-09-11 0

STEIN JEFFREY PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2013-09-11 0

SCHMID JOHN P. CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2013-09-11 0

PROKOCIMER PHILIPPE CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2013-09-11 0

SCHROEDER THEODORE R

  • Director
0 2013-09-11 0

EASTHAM KARIN

  • Director
No longer subject to file 2013-09-11 0

TRUEX PAUL F

  • Director
No longer subject to file 2013-09-11 0

KABAKOFF DAVID S

  • Director
No longer subject to file 2013-09-11 0

BARTIZAL KEN CHIEF DEVELOPMENT OFFICER

  • Officer
No longer subject to file 2013-09-11 0

O'LEARY BRENDAN

  • Director
No longer subject to file 2013-09-11 0

THOMPSON JOHN CRAIG CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2013-09-11 0

MORNEAU MICHAEL VP FINANCE & CAO

  • Officer
No longer subject to file 2013-09-11 0

FISCHER SETH H.Z.

  • Director
No longer subject to file 2013-09-11 0

ONAITIS MATTHEW GENERAL COUNSEL

  • Officer
No longer subject to file 2013-09-11 0

KPCB PBD FOUNDERS FUND, LLC

  • 10% Owner
No longer subject to file 2013-05-10 0

KPCB PANDEMIC & BIO DEFENSE FUND LLC

  • 10% Owner
No longer subject to file 2013-05-10 0

STACK RISA

  • Director
591 2013-05-10 0

POWELL MICHAEL

  • Director
9,302 2012-03-26 0

SOFINNOVA VENTURE PARTNERS VII L P

SOFINNOVA MANAGEMENT VII, L.L.C.

HEALY JAMES

BUATOIS ERIC

  • 10% Owner
No longer subject to file 2012-01-12 0

PRISM VENTURE PARTNERS V L P

PRISM VENTURE PARTNERS V-A LP

  • 10% Owner
2,958,230 2010-08-06 0

KPCB PBD ASSOCIATES, LLC

  • 10% Owner
2,392,026 2010-08-06 0

INTERWEST PARTNERS IX, LP

EHRLICH CHRISTOPHER B

GRAIS LINDA S

NASR KHALED

PEPPER DOUGLAS A

  • 10% Owner
  • VENTURE MEMBERVENTURE MEMBERVENTURE MEMBERSVENTURE MEMBER
3,548,643 2010-08-06 0

INTERWEST PARTNERS IX, LP

INTERWEST MANAGEMENT PARTNERS IX, LLC

CASH HARVEY B

GIANOS PHILIP T

HOLMES W STEPHEN

KLIMAN GILBERT H

ORONSKY ARNOLD L

ROSCH THOMAS L

SWEENEY MICHAEL B

CLEVELAND BRUCE A

  • 10% Owner
  • GENERAL PARTNERMANAGING DIRECTORMANAGING DIRECTORMANAGING DIRECTORMANAGING DIRECTORMANAGING DIRECTORMANAGING DIRECTORMANAGING DIRECTORVENTURE MEMBER
3,548,643 2010-08-06 0

SOFINNOVA VENTURE PARTNERS VII L P

  • 10% Owner
3,615,572 2010-08-06 0

VERSANT VENTURE CAPITAL III, L.P.

VERSANT SIDE FUND III, L.P.

  • 10% Owner
3,235,839 2010-08-06 0

VERSANT VENTURE CAPITAL III, L.P.

VERSANT SIDE FUND III, L.P.

ATWOOD BRIAN G

  • Director
  • 10% Owner
0 2010-08-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments